0.1510
+0.0330
+(27.97%)
At close: January 23 at 7:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-4,381
-4,381
-4,368
-2,146
Investing Cash Flow
359
359
-388
-81
Financing Cash Flow
--
--
--
23,176
End Cash Position
12,171
12,171
16,193
20,949
Capital Expenditure
-175
-175
-597
-81
Issuance of Capital Stock
--
--
--
23,176
Issuance of Debt
--
--
--
225
Repayment of Debt
--
--
--
-225
Free Cash Flow
-4,556
-4,556
-4,965
-2,227
12/31/2021 - 4/1/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
OMY.SG Synairgen plc
0.0145
+26.09%
ONCT Oncternal Therapeutics, Inc.
0.5266
-24.12%
HOOK HOOKIPA Pharma Inc.
1.4100
-7.84%
SNGX Soligenix, Inc.
2.2000
-4.76%
ALEC Alector, Inc.
1.4100
-14.02%
ADVM Adverum Biotechnologies, Inc.
4.1600
-11.68%
PHAT Phathom Pharmaceuticals, Inc.
5.21
-5.62%
CANF Can-Fite BioPharma Ltd.
1.7200
-2.27%
CABA Cabaletta Bio, Inc.
1.6700
-7.48%
HRTX Heron Therapeutics, Inc.
2.2400
-9.31%